Cinitapride is a benzamide-class gastroprokinetic and antiulcer agent indicated for the treatment of gastrointestinal motility disorders, including gastroesophageal reflux disease, non-ulcer dyspepsia,… Read more




![Chemical structure of 4-[(4-Amino-2-ethoxy-5-nitrobenzoyl)amino]-1-piperidinecarboxylic Acid Ethyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F952309-99-8-4-4-Amino-2-ethoxy-5-nitrobenzoylamino-1-piperidinecarboxylic-Acid-Ethyl-Ester.png&w=3840&q=75)











































Cinitapride is a benzamide-class gastroprokinetic and antiulcer agent indicated for the treatment of gastrointestinal motility disorders, including gastroesophageal reflux disease, non-ulcer dyspepsia, and delayed gastric emptying. This category provides essential reference standards for the Cinitapride active pharmaceutical ingredient (API), as well as a comprehensive selection of its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these high-quality materials to ensure accuracy in analytical testing, method validation, and impurity profiling throughout the drug development and manufacturing lifecycle. By incorporating these precise reference standards, researchers can reliably monitor product quality and regulatory compliance, ensuring that trace-level impurities are identified and quantified effectively during rigorous quality control processes.